Pre Approval Inspections And Alternative Approaches To Facility Assessment 415 Global Quality

Summary

Mahesh Ramanadham and Derek Smith, CDER Office of Pharmaceutical The FDA Group's CEO, Nick Capman, sits down with Former FDA Investigator, Christopher Smith to dive deep into FDA ... Zhihao Peter Qiu, CDER Office of Pharmaceutical Rakhi Shah, CDER Office of Pharmaceutical Sean Marcsisin from the FDA Office of Regulatory Affairs explains the FDA's Office of Regulatory Affairs' Lucila B. Nwatu describes the general inspectional Rakhi B. Shah from CDER's Office of Pharmaceutical Have you considered the consequence for your Rakhi Shah, Mahesh Ramanadham, Derek Smith, and Zhihao Peter Qiu respond to audience questions. FDA CDER's Small ... Aditi Thakur from CDER's Office of Pharmaceutical FDA discusses an overview of the agency's